Tag Archives: Plegridy

Biogen’s 2Q Profit Crushes Views; CEO to Depart

Biogen Inc. (Cambridge MA) stock jumped Thursday after the drugmaker reported strong sales of some of its newest treatments for multiple sclerosis and hemophilia. The company’s net income and sales… Read more »